New medicines for Type 2 diabetes in adolescents: many products, few patients

ISSN： 1751-2433

Source： Expert Review of Clinical Pharmacology, Vol.6, Iss.3, 2013-05, pp. : 227-229

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Fasiglifam as a new potential treatment option for patients with type 2 diabetes

By Kaku Kohei

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 18, 2013-12 ,pp. : 2591-2600

Informa Healthcare

Access to resources Recommend Favorite

Treating type 2 diabetes in children and adolescents

Inpharma, Vol. 1, Iss. 1233, 2000-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Increasing Incidence of Type 2 Diabetes in Children and Adolescents: Treatment Considerations

By Rosenbloom A.L.

Pediatric Drugs, Vol. 4, Iss. 4, 2002-01 ,pp. : 209-221

Adis International

Access to resources Recommend Favorite

The Pharmaceutical care of patients with type 2 diabetes mellitus

By Borges Anna

Pharmacy World and Science, Vol. 32, Iss. 6, 2010-12 ,pp. : 730-736

Springer Publishing Company

Access to resources Recommend Favorite

Enhanced RBC Aggregation in Type 2 Diabetes Patients

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 29, Iss. 5, 2015-09 ,pp. : 387-389

John Wiley & Sons Inc

Access to resources Recommend Favorite